Endoscopy cornerDoes Stent Placement for Advanced Colon Cancer Increase the Risk of Perforation During Bevacizumab-Based Therapy?
References (20)
- et al.
Colonic stents for malignant obstruction—not a bridge too far?
Gastrointest Endosc
(2006) - et al.
WallFlex colonic stent placement for management of malignant colonic obstruction: a prospective study at two centers
Gastrointest Endosc
(2008) - et al.
Ultraflex precision colonic stent placement as a bridge to surgery in patients with malignant colon obstruction
Gastrointest Endosc
(2008) - et al.
Management of bevacizumab-associated bowel perforation: a case series and review of the literature
Ann Oncol
(2008) - et al.
What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
Gynecol Oncol
(2007) - et al.
Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management
Curr Surg
(2006) - et al.
Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis
Lancet Oncol
(2009) - et al.
Emergency surgery for colon carcinoma
Dis Colon Rectum
(2003) - et al.
Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer
Br J Surg
(2003) Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract
N Engl J Med
(2001)
There are more references available in the full text version of this article.
Cited by (82)
Colorectal stenting for palliation and bridge to surgery of obstructing cancer
2020, Techniques and Innovations in Gastrointestinal EndoscopySafety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents
2019, Clinical Colorectal CancerCitation Excerpt :BV is broadly used in patients with advanced CRC, and gastrointestinal perforations represent a well-known but infrequent complication, occurring in every 60 to 200 treated patients.11,12,29 Patients with occlusive colon cancer treated with stent placement and scheduled for BV-based therapy may have an increased risk of colon perforation,27,28 with SEMS placement representing an additional factor that further increases such risk. However, despite observing more stent-related complications in patients treated with BV-based regimens, patients with metastatic colon cancer benefit from chemotherapy and antiangiogenic agents after SEMS implantation, showing an association with survival.
To resect or not to resect: The hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer
2018, Critical Reviews in Oncology/HematologySafety and efficacy of palliative systemic chemotherapy combined with colorectal self-expandable metallic stents in advanced colorectal cancer: A multicenter study
2016, Clinics and Research in Hepatology and Gastroenterology
Conflicts of interest The authors disclose no conflicts.
Copyright © 2009 AGA Institute. Published by Elsevier Ltd. All rights reserved.